InvestSMART

Kazia Therapeutics Limited (ASX: KZA) - Announcements

DELISTED - Current share price for KZA : $0.080

ASX company news and announcements for Kazia Therapeutics Limited (KZA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Kazia Therapeutics Limited (KZA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Kazia Therapeutics Limited (KZA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Kazia Therapeutics Limited (KZA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Application for quotation of securities - KZA 15 Aug 2022 8:19AM $0.250 $0.080 fallen by 68%
- Change in substantial holding 10 Aug 2022 4:34PM $0.250 $0.080 fallen by 68%
- Change in substantial holding 10 Aug 2022 8:20AM $0.260 $0.080 fallen by 69.23%
- Notification of cessation of securities - KZA 8 Aug 2022 3:23PM $0.270 $0.080 fallen by 70.37%
- Interim data from MSKCC study 8 Aug 2022 8:01AM $0.250 $0.080 fallen by 68%
- GBM Agile Update 1 Aug 2022 9:02AM $0.510 $0.080 fallen by 84.31%
- Quarterly Activities/Appendix 4C Cash Flow Report 29 Jul 2022 4:24PM $0.510 $0.080 fallen by 84.31%
- Quarterly Activities/Appendix 4C Cash Flow Report 29 Jul 2022 7:54AM $0.495 $0.080 fallen by 83.84%
- Kazia launches new SAB 12 Jul 2022 8:21AM $0.610 $0.080 fallen by 86.89%
- Cleansing notice 8 Jul 2022 6:00PM $0.620 $0.080 fallen by 87.10%
- Application for quotation of securities - KZA 8 Jul 2022 5:58PM $0.620 $0.080 fallen by 87.10%
- FDA grants RPDD to paxaliaib for AT/RT 6 Jul 2022 5:57PM $0.620 $0.080 fallen by 87.10%
- Kazia progress update 30 Jun 2022 8:21AM $0.615 $0.080 fallen by 86.99%
- Ceasing to be a substantial holder 27 Jun 2022 7:01PM $0.620 $0.080 fallen by 87.10%
- Change in substantial holding 27 Jun 2022 8:16AM $0.660 $0.080 fallen by 87.88%
- Cleansing notice 24 Jun 2022 4:17PM $0.660 $0.080 fallen by 87.88%
- Application for quotation of securities - KZA 24 Jun 2022 4:06PM $0.660 $0.080 fallen by 87.88%
- Kazia presentation on paxalisib for childhood brain cancer 23 Jun 2022 6:05PM $0.625 $0.080 fallen by 87.20%
- Change in substantial holding 23 Jun 2022 8:23AM $0.670 $0.080 fallen by 88.06%
- Cleansing Notice 17 Jun 2022 7:05PM $0.745 $0.080 fallen by 89.26%
- Application for quotation of securities - KZA 17 Jun 2022 7:02PM $0.745 $0.080 fallen by 89.26%
- Kazia's paxalisib gains ODD for ATRT 17 Jun 2022 11:24AM $0.758 $0.080 fallen by 89.44%
- FDA AWARDS ORPHAN DESIGNATION TO PAXALISIB FOR ATRT 17 Jun 2022 9:17AM $0.740 $0.080 fallen by 89.19%
- Kazia paxalisib preclinical DIPG data released at IPSNO 14 Jun 2022 8:07AM $0.780 $0.080 fallen by 89.74%
- Cleansing notice 10 Jun 2022 5:06PM $0.780 $0.080 fallen by 89.74%

126 - 150 of 476 results

Page 6 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.